# Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma

> **NCT05151224** · — · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 40 (estimated)

## Conditions studied

- Breast Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** microRNA 21

## Key facts

- **NCT ID:** NCT05151224
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12
- **Primary completion:** 2023-12
- **Final completion:** 2024-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05151224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05151224, "Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05151224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*